Erythroxylum coca

Erythroxylum coca is an Amazonian plant containing cocaine alkaloids and polyphenols traditionally used by Andean peoples for energy and altitude adaptation. The primary bioactive compounds work through dopamine and norepinephrine reuptake inhibition, though clinical evidence is limited to traditional use patterns.

Origin & History

Erythroxylum coca is a shrub native to the Andean regions of Bolivia, Peru, and Colombia, growing in tropical mountain forests and lowlands. The leaves are harvested from the plant and contain tropane alkaloids including cocaine (0.23-0.96% in dry leaves), along with dietary fiber (>50%), sugars, and polyphenols.

Historical & Cultural Context

Erythroxylum coca leaves have been chewed for centuries by Aymara and Quechua peoples in Bolivia and Peru as a general stimulant, with preference for sweeter Yungas varieties. Use dates back millennia in South American indigenous cultures for energy and altitude sickness relief.

Health Benefits

• Traditional stimulant properties - used by Andean peoples for energy and altitude sickness relief (traditional use only, no clinical trials)
• High dietary fiber content (>50% in leaves) - may support digestive health (compositional analysis only)
• Contains polyphenols (1.2-1.5 mg eq AG/g) - potential antioxidant properties (preliminary evidence)
• Rich in organic acids including succinic acid (11,666 mg/g) - possible metabolic support (compositional data only)
• Traditional use for pleasant stimulation and tea-like effects (historical use only, no RCTs)

How It Works

The primary alkaloids in Erythroxylum coca, including cocaine (0.5-1% in leaves), function as monoamine reuptake inhibitors, blocking dopamine, norepinephrine, and serotonin transporters. Secondary compounds like polyphenols (1.2-1.5 mg eq AG/g) may provide antioxidant activity through free radical scavenging mechanisms. The high fiber content (>50%) supports digestive function through mechanical and prebiotic pathways.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for Erythroxylum coca leaves or extracts. One compositional study (PMID: 9201607) analyzed Bolivian E. coca leaves but reported no clinical outcomes. Research focuses primarily on chemical composition rather than clinical efficacy.

Clinical Summary

No controlled clinical trials exist for Erythroxylum coca as a supplement ingredient. Evidence is limited to ethnobotanical studies documenting traditional use patterns among Andean populations for energy and altitude sickness management. Compositional analyses confirm alkaloid content and fiber levels, but therapeutic efficacy remains unestablished. Legal restrictions severely limit research opportunities for clinical investigation.

Nutritional Profile

Erythroxylum coca leaves present a distinctive nutritional composition documented primarily through phytochemical and compositional analyses. Dietary fiber is the dominant macronutrient component, exceeding 50% dry weight of the leaf material, with structural polysaccharides comprising the bulk of this fraction. Protein content in dried coca leaves has been reported at approximately 19-20% dry weight in select analyses, notably higher than many conventional leafy botanicals, though bioavailability via traditional chewing/infusion methods is substantially reduced compared to direct consumption. Fat content is low, estimated at 3-5% dry weight. The primary bioactive alkaloid fraction totals approximately 0.5-1.0% dry weight in cultivated leaves, dominated by cocaine alkaloids alongside cinnamoylcocaine derivatives (truxillines), tropacocaine, and hygrine; these compounds are responsible for the traditional stimulant and anesthetic effects and are not nutritionally relevant in a conventional dietary sense. Polyphenol content has been quantified at 1.2-1.5 mg gallic acid equivalents per gram, encompassing flavonoids and hydroxycinnamic acid derivatives with preliminary antioxidant activity. Organic acid profile includes succinic acid, malic acid, and citric acid as primary identified constituents. Mineral content documented in Andean ethnobotanical analyses includes calcium (approximately 997 mg/100g dry weight), iron (approximately 26 mg/100g dry weight), and phosphorus, with bioavailability enhanced by the alkaline ash (llipta or cal) traditionally co-administered during chewing, which raises oral pH and facilitates alkaloid and mineral release. Vitamins A, B2 (riboflavin), and C have been reported in compositional studies of dried leaf, with vitamin C estimates ranging 2-10 mg/100g depending on processing. Bioavailability of most constituents via infusion (mate de coca) is considerably lower than chewing with alkaline adjuncts, and dried/processed leaf forms show further degradation of thermolabile compounds.

Preparation & Dosage

No clinically studied dosage ranges have been established for Erythroxylum coca extracts, powders, or standardized forms. Traditional use involves chewing dried leaves, but no quantified doses from clinical studies are available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Maca root, Rhodiola rosea, Eleuthero, Schisandra berry, Cordyceps

Safety & Interactions

Erythroxylum coca contains controlled substances (cocaine alkaloids) that are illegal in most jurisdictions. Even traditional preparations may cause cardiovascular stimulation, anxiety, and dependence potential. The plant may interact with MAO inhibitors, stimulant medications, and cardiovascular drugs through its alkaloid content. Pregnancy and lactation use is contraindicated due to alkaloid transfer risks and lack of safety data.